Clinical and Multidisciplinary Hematology and Oncology: The 13th Annual Review 2016
Course Directors: Joseph R. Mikhael, MD; Donald W. Northfelt, MD; Alan H. Bryce, MD
This course will provide multidisciplinary comprehensive update and management strategies of issues in hematologic and oncologic malignancies presenting new disease classification, treatment, and challenging cases. Topics focus on key hematologic diseases (dysproteinemias, acute and chronic leukemias, lymphomas), key solid tumors (breast, GI, GU), and overlap topics of supportive, ancillary and diagnostic care. AMA, Nursing and Pharmacy CE credits are offered at this course.
Program Schedule
Registration
Before January 8, 2016 | After January 8, 2016 | |
M.D., PhD, D.O. | $525.00 | $600.00 |
R.N., N.P., P.A., Pharmacist | $250.00 | $325.00 |
Additional Information
Course Credit
Meeting Location and Accommodations
Course Postcard
Course Brochure
Exhibitor Information
Exhibit Opportunties
This course offers the unique opportunity for commercial companies to interact with health care providers and highlight their products and services. If you are interested in exhibit space during this course, please contact: exhibits@mayo.edu
Target Audience
This course is designed for Hematologists, Oncologists, Physician Assistants, Nurse Practitioners, Nurses, Pharmacists, and those interested in the diagnosis and treatment of hematologic and oncology disorders.
Learning Objectives
Upon completion of this course, participants should be able to:
- Provide an update in key clinical areas of hematology, palliative care, medical/ surgical/radiation oncology
- Discuss the clinical utility of new targeted therapies for chronic lymphocytic leukemia
- Explain new options of therapy for relapsed multiple myeloma.
- Review advances in biology and management of myelodysplastic syndromes.
- Discuss proton radiotherapy and its indication for cancer treatment.
- Provide an overview of molecular targeting of therapy for metastatic non-small cell lung cancer.
- Review current management strategies for various situations in breast cancer based on interactive case discussions.
- Identify risks and benefits of new oral anticoagulants.
Available Credit
- 19.75 AAFP Prescribed
- 20.75 AMA PRA Category 1 Credit™
- 19.75 ANCC
- 20.75 AOA
- 20.75 Attendance